News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
FDA to Cut Back Hiring of Non-US Citizens
Shawna Williams | Aug 14, 2017
The move appears to be out of step with other HHS agencies.
Right-to-Try Bill Passes the Senate
Catherine Offord | Aug 4, 2017
The legislation removes restrictions for seriously ill patients to access experimental treatments that have not received FDA approval.
Smallpox Kerfuffle Reveals Biosecurity Problems
Kerry Grens | Jul 12, 2017
A review of a 2014 incident in which mystery vials of smallpox were found at the NIH reveals security weaknesses, but also concludes the response was appropriate.
Opinion: Token Pharmacovigilance
Peter Doshi | May 23, 2017
A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?
New FDA Pathway to Accelerate Development of Cell Therapies
Jef Akst | May 22, 2017
Four products have already qualified for the regenerative medicine advanced therapy (RMAT) designation that provides extra interactions with the agency, and sooner.
Second-Ever ALS Drug Approved
Jef Akst | May 8, 2017
Amyotrophic lateral sclerosis patients in the U.S. now have an option besides riluzole, which was approved by the FDA more than two decades ago and only extends life by two or three months.
Drugs OKed Faster in U.S. Than in Europe
Kerry Grens | Apr 10, 2017
In recent years, the US Food and Drug Administration has approved more drugs and in less time than the European Medicines Agency.
FDA OKs Marketing of DTC Genetic Health-Risk Tests
Diana Kwon | Apr 7, 2017
23andMe customers can now receive information about genetic risk for diseases including Parkinson’s and celiac.
Notable Science Quotes
Staff | Apr 1, 2017
Eugene Garfield, the cancer moonshot, employee genetic testing, and more
Scott Gottlieb Nominated to Lead the FDA
Joshua A. Krisch | Mar 13, 2017
President Donald Trump has nominated physician Scott Gottlieb to be the next FDA commissioner.